Back to User profile » Dr Zhihui Wang

Papers published by Dr Zhihui Wang:


CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma

Wang ZH, Pei XF, Zhu ZQ, Lin Z, Mao YY, Xu XL, Luo YL, Zhang L, Peng PJ

OncoTargets and Therapy 2020, 13:3325-3334

Published Date: 21 April 2020

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Lin Z, Lv WZ, Wang SY, Zou JL, Con YY, Wang ZH, Xiao M, Peng PJ

Cancer Management and Research 2017, 9:671-677

Published Date: 20 November 2017

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ

OncoTargets and Therapy 2016, 9:6195-6201

Published Date: 11 October 2016

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

Peng PJ, Lv BJ, Tang C, Liao H, Lin Z, Liu YM, Wang ZH, Wang SY, Cheng ZB

Drug Design, Development and Therapy 2015, 9:6401-6405

Published Date: 10 December 2015